What is Gilenya?
Gilenya, a brand name for the drug fingolimod, is used to treat relapsing forms of multiple sclerosis (MS) by decreasing the number of MS flare-ups (relapses).
Reported Purpose & Perceived Effectiveness
| Perceived Effectiveness | |||||||
|---|---|---|---|---|---|---|---|
| Purpose | # of patients | # of patients with evaluations | Major | Moderate | Slight | None | Can’t tell |
| MS (Multiple Sclerosis) | 235 | 98 |
|
|
|
|
|
| Diabetes Type 2 | 1 | 0 | |||||
| These side effects have beenprogrammed out and are no longer problem for me | 1 | 1 |
|
||||
| Relapse MS (exacerbation) | 1 | 1 |
|
||||
| Familial ALS | 1 | 0 | |||||
See all 207 patients currently taking Gilenya
Mouse over the table for more information
Reported Side Effects
Commonly reported side effects, conditions, and hospitalizations associated with Gilenya
| Headaches | 6 | |
|---|---|---|
| Heart palpitations | 5 | |
| Fatigue | 5 | |
| Elevated liver enzymes | 4 | |
| Dizziness | 4 | |
| Nausea | 3 | |
| See all 82 reported side effects ▼ | ||
Reported Dosages
Frequently reported dosages based on patients currently taking Gilenya. See all 23 dosages ►
Reported Stop Reasons
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Doctor's advice | 24 | ||
| Side effects too severe | 23 | ||
| Did not seem to work | 18 | ||
| Other | 12 | ||
| Personal research | 3 | ||
| Expense | 1 | ||
| Not indicated | 1 |
Reported Duration See details about how long patients take this treatment ▼
Reported Adherence, Burden & Cost See details from patient evaluations ▼
Adherence
Taking treatment as prescribed
Adherence of Gilenya
Always |
96 | 93% |
|
|---|---|---|---|
Usually |
2 | 2% |
|
Sometimes |
1 | 1% |
|
Never |
4 | 4% |
|
Burden
Difficulty being on treatment
Burden of Gilenya
Very |
3 | 3% |
|
|---|---|---|---|
Somewhat |
3 | 3% |
|
A little |
3 | 3% |
|
Not at all |
94 | 91% |
|
Cost
Paid out of pocket
Cost of Gilenya
$200+ |
8 | 9% |
|
|---|---|---|---|
$100-199 |
9 | 11% |
|
$50-99 |
7 | 8% |
|
$25-49 |
14 | 16% |
|
< $25 |
47 | 55% |
|
Updating results…










First
Pre
